Highlight
This multicenter randomized clinical trial demonstrated that personalized blood pressure (BP) management guided by reperfusion quality after endovascular therapy for acute ischemic stroke significantly improved functional outcomes at 90 days compared to guideline-recommended BP targets. The intervention group experienced lower rates of hemorrhagic transformation without increased rates of symptomatic intracranial hemorrhage or mortality, endorsing a patient-specific approach to post-thrombectomy BP control.
